Arctoris welcomes on board globally recognized experts in Machine Learning, Chemical Computation, and Alzheimer’s Disease
Joining Arctoris as scientific advisors are Rafael Gómez Bombarelli (MIT), John Davis (University of Oxford) and Teodoro Laino (IBM) (left to right) Oxford, October 4, 2022. Arctoris Ltd, a tech-enabled biopharma platform company, has appointed three globally recognized experts in Alzheimer’s disease, Machine Learning applied to closed loop discovery, and automated chemistry as members of […]
Cyclica and Arctoris to expand partnership to advance drug discovery programs for Alzheimer’s disease
Cyclica and Arctoris Extend Partnership Combining Polypharmacology and Machine Learning Platforms to Develop Medicines Toronto, Canada and Oxford, UK – Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline, and Arctoris Ltd. (“Arctoris”), a tech-enabled biopharma company that combines its unique automation with computational approaches to […]
Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC). The partnership brings together two highly synergistic approaches for AI-guided and robotics-powered molecule design, to significantly accelerate the DMTA (Design, Make, Test, Analyze) cycle. Oxford and London – Arctoris, a tech-enabled biopharma company, and […]
IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud
Ulysses is the world’s first fully automated drug discovery platform developed and operated by Arctoris based in Oxford, Boston, and Singapore. Oxford and Zurich, September 2021. Today, IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. IBM Research has developed RXN for Chemistry, an […]
Arctoris Celebrates 5th Anniversary and Launches Its Expanded Robotic Platform Ulysses
Ulysses is an advanced, fully automated robotic platform developed and operated by Arctoris that provides superior quality data and accelerates drug discovery OXFORD, UK – 10 February 2021. Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its 5th anniversary on the 4th of February. Over the past five years, Arctoris […]
Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow
Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment OXFORD, UK – 17 December 2020. Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment Medicines discovery innovators, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence […]
Arctoris appoints three experienced industry executives as members of its Advisory Board
Joining Arctoris in senior roles are Beth J Hoffman PhD, Prof Khusru Asadullah MD and Stanley Lapidus (left to right) OXFORD, UK – 8 December 2020. Arctoris Ltd, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Professor Khusru […]
Arctoris and Syntekabio Form Research Partnership
Syntekabio and Arctoris join their forces in the fight against COVID-19. Together, they substantially accelerate drug discovery by combining their leading technologies: Syntekabio’s in silico modeling simulation and Arctoris’ fully-automated in vitro validation. OXFORD, UK – 8 September 2020. Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of […]
Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI
Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI (Credit: Insilico) OXFORD, UK – 09 July 2020. Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, today announced a technology partnership with Arctoris, the world’s first fully automated drug discovery platform, offering remotely accessible, pre-optimised and fully […]
Arctoris contributes its capabilities and expertise to the fight against COVID-19
OXFORD, UK – 07 July 2020. Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19. Scientists in academic centres and companies around the world desperately search for novel therapeutics and vaccines to treat and prevent COVID-19. However, with lockdowns and limited access to laboratories, researchers are being forced to work from home, putting research […]